NewLink Genetics Company
NewLink Genetics, a biopharmaceutical company, develops therapeutic and diagnostic agents for patients with cancer and infectious diseases.
Total Funding:
33594000
Headquarters:
Ames, Iowa, United States
Funding Status:
IPO
Employee Number:
51-100
Last Funding Type:
Series D
Last Funding Date:
2009-07-21
Investors Number:
5
Founded Date:
1999-01-01
Industry:
Whole-Cell Antigens